Literature DB >> 6498140

Exogenous ocular candidiasis associated with intravenous heroin abuse.

T C Sorrell, C Dunlop, P J Collignon, J A Harding.   

Abstract

Seven young men developed disseminated candidiasis within 10 days of a single episode of intravenous heroin abuse. Sequential development of eye and skin lesions was noted in all cases. The bone or costal cartilage was involved in five. Ocular manifestations of candidiasis included episcleritis, chorioretinitis, and endophthalmitis. A presumptive diagnosis of candida chorioretinitis was established rapidly by culture of Candida albicans from involved skin and costal cartilage. Systemic therapy with amphotericin B plus 5-fluorocytosine resulted in cure of the episcleritis, chorioretinitis, osteomyelitis, costochondritis, and skin infection. Pars plana vitrectomy with local instillation of amphotericin B was required to cure chorioretinitis associated with vitreal extension of infection.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6498140      PMCID: PMC1040483          DOI: 10.1136/bjo.68.11.841

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  15 in total

1.  Candida endophthalmitis.

Authors:  M J Horne; R F Taylor; R Williams; W Zylstra
Journal:  Med J Aust       Date:  1975-02-08       Impact factor: 7.738

Review 2.  Ocular manifestations of Candida septicemia: review of seventy-six cases of hematogenous Candida endophthalmitis.

Authors:  J E Edwards; R Y Foos; J Z Montgomerie; L B Guze
Journal:  Medicine (Baltimore)       Date:  1974-01       Impact factor: 1.889

3.  Intravitreal amphotericin B toxicity.

Authors:  E N Souri; W R Green
Journal:  Am J Ophthalmol       Date:  1974-07       Impact factor: 5.258

4.  Toxicity of intravitreal injection of amphotericin B.

Authors:  A J Axelrod; G A Peyman; D J Apple
Journal:  Am J Ophthalmol       Date:  1973-10       Impact factor: 5.258

5.  Intravitreal amphotericin B treatment of Candida endophthamitis.

Authors:  G A Stern; C L Fetkenhour; R B O'Grady
Journal:  Arch Ophthalmol       Date:  1977-01

6.  Candida endophthalmitis and infection of costal cartilages.

Authors:  P C Ho; D M O'Day
Journal:  Br J Ophthalmol       Date:  1981-05       Impact factor: 4.638

7.  Candida endophthalmitis and drug abuse.

Authors:  K H Tarr
Journal:  Aust J Ophthalmol       Date:  1980-11

8.  Candida endophthalmitis after intravenous drug abuse.

Authors:  G L Aguilar; M S Blumenkrantz; P R Egbert; J P McCulley
Journal:  Arch Ophthalmol       Date:  1979-01

Review 9.  Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy.

Authors:  J E Edwards; R I Lehrer; E R Stiehm; T J Fischer; L S Young
Journal:  Ann Intern Med       Date:  1978-07       Impact factor: 25.391

10.  Pars plana vitrectomy in the management of endogenous Candida endophthalmitis.

Authors:  R C Snip; R G Michels
Journal:  Am J Ophthalmol       Date:  1976-11       Impact factor: 5.258

View more
  4 in total

1.  Diagnostic pars plana vitrectomy report of a 21-year retrospective study.

Authors:  G N Palexas; W R Green; M F Goldberg; Y Ding
Journal:  Trans Am Ophthalmol Soc       Date:  1995

2.  Candida osteomyelitis: analysis of 207 pediatric and adult cases (1970-2011).

Authors:  Maria N Gamaletsou; Dimitrios P Kontoyiannis; Nikolaos V Sipsas; Brad Moriyama; Elizabeth Alexander; Emmanuel Roilides; Barry Brause; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2012-08-21       Impact factor: 9.079

3.  Experimental study of the intra-ocular penetration of ketoconazole in rabbits.

Authors:  F Malecaze; M D Linas; A Mathis; J L Arne; P Recco; M H Bessieres; P Bec
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

4.  Endogenous candida endophthalmitis.

Authors:  A H Chignell
Journal:  J R Soc Med       Date:  1992-12       Impact factor: 18.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.